Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Light Chain Deposition Disease”

19 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 19 results

Testing effectiveness (Phase 2)WithdrawnNCT05486481
What this trial is testing

Venetoclax, Daratumumab, and Dexamethasone for Systemic Light-Chain Amyloidosis With Translocation (11;14) (ALTITUDE)

Who this might be right for
AL AmyloidosisLight Chain (AL) AmyloidosisSystemic Light Chain Disease
Alfred Chung, MD
Not applicableEnded earlyNCT01018927
What this trial is testing

Detecting Early Myocardial Infiltration w/Amyloid & Light Chain Deposition Disease in Multiple Myeloma Subjects

Who this might be right for
Multiple Myeloma
University of Arkansas 44
Not applicableUnknownNCT05150353
What this trial is testing

Detection of Amyloid Deposits in the Wrist by MRI With Mapping and High Resolution Sequences in Systemic Amyloidosis (AMYLOCARP)

Who this might be right for
AmyloidSystemic Amyloidosis
Ramsay Générale de Santé 140
Early research (Phase 1)Study completedNCT00890747
What this trial is testing

Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAcute Undifferentiated Leukemia+82 more
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Study completedNCT01849783
What this trial is testing

Autologous Stem Cell Transplant Followed By Maintenance Therapy in Treating Elderly Patients With Multiple Myeloma

Who this might be right for
Extramedullary PlasmacytomaIsolated Plasmacytoma of BoneLight Chain Deposition Disease+4 more
Margarida Magalhaes-Silverman 41
Early research (Phase 1)Active Not RecruitingNCT03820817
What this trial is testing

Rifaximin in Patients With Monoclonal Gammopathy

Who this might be right for
IgA Monoclonal GammopathyIgG Monoclonal GammopathyIgM Monoclonal Gammopathy+6 more
Emory University 50
Early research (Phase 1)Ended earlyNCT01728259
What this trial is testing

First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDD

Who this might be right for
Light Chain Deposition DiseasePrimary Systemic Amyloidosis
Barbara Ann Karmanos Cancer Institute 18
Testing effectiveness (Phase 2)WithdrawnNCT03130348
What this trial is testing

Ibrutinib With or Without Bortezomib and Dexamethasone in Treating Patients With Relapsed or Refractory Immunoglobulin Light Chain Amyloidosis

Who this might be right for
AmyloidosisImmunoglobulin Light Chain Deposition
Mayo Clinic
Not applicableLooking for participantsNCT06065852
What this trial is testing

National Registry of Rare Kidney Diseases

Who this might be right for
Adenine Phosphoribosyltransferase DeficiencyAH AmyloidosisAHL Amyloidosis+81 more
UK Kidney Association 35,000
Not applicableStudy completedNCT01383759
What this trial is testing

Bortezomib/Dexamethasone (BD), Followed By Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone For the Initial Treatment of Monoclonal Immunoglobulin Deposition Disease (MIDD) Associated With Multiple Myeloma and AL Amyloidosis

Who this might be right for
Light Chain Deposition Disease (LCDD or MIDD)Light Chain and Heavy Chain Deposition Disease (LHCDD or MIDD)Monoclonal Immunoglobulin Deposition Disease (MIDD)+1 more
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT01533194
What this trial is testing

Viral Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Light Chain Deposition DiseaseRefractory Plasma Cell Myeloma
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Study completedNCT00520767
What this trial is testing

Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease

Who this might be right for
Primary Systemic AmyloidosisLight Chain Deposition Disease
Barbara Ann Karmanos Cancer Institute 35
Large-scale testing (Phase 3)Study completedNCT01078454
What this trial is testing

Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis

Who this might be right for
Light Chain Deposition DiseasePrimary Systemic Amyloidosis
National Cancer Institute (NCI) 11
Not applicableLooking for participantsNCT05283993
What this trial is testing

A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH

Who this might be right for
Multiple MyelomaAmyloidosisCryoglobulinemia+9 more
Peking University First Hospital 2,000
Testing effectiveness (Phase 2)Ended earlyNCT00681044
What this trial is testing

HD Melphalan and SCT in Patients With IGDD or LCDD

Who this might be right for
Multiple Myeloma
Boston Medical Center 5
Testing effectiveness (Phase 2)Study completedNCT03499808
What this trial is testing

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

Who this might be right for
Amorphous, Eosinophilic, and Acellular DepositConstipationDiarrhea+10 more
SWOG Cancer Research Network 43
Testing effectiveness (Phase 2)Looking for participantsNCT06418477
What this trial is testing

Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone Therapy for Patients with MIDD

Who this might be right for
Monoclonal Gammopathy of Renal Significance
Peking University People's Hospital 20
Not applicableLooking for participantsNCT03717844
What this trial is testing

Registry for Adults With Plasma Cell Disorders (PCD's)

Who this might be right for
Multiple MyelomaAmyloidosisCryoglobulinemia+6 more
UNC Lineberger Comprehensive Cancer Center 2,000
Large-scale testing (Phase 3)Active Not RecruitingNCT01169337
What this trial is testing

Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma

Who this might be right for
Light Chain Deposition DiseaseSmoldering Multiple Myeloma
National Cancer Institute (NCI) 226
20